Monitoring activity in the amygdala — the part of the brain that detects and responds to danger — can help determine who will become depressed or anxious in response to stressful life events, according to a new study.
“Often, individuals only access treatment when depression and anxiety has become so chronic and difficult to live with that it forces them to go to a clinic,” said the study’s first author Johnna Swartz, Ph.D., a Duke postdoctoral researcher in the lab of senior author Dr. Ahmad Hariri.
“With a brain marker, we could potentially guide people to seek treatment earlier on, before the disorders become so life altering and disruptive that the person can’t go on.”
For the new study, Hariri’s team scanned the brains of healthy college students as they looked at angry or fearful faces, which signal danger in our environment. These threatening pictures normally trigger the amygdala, and the scientists measured the intensity of this activation using functional magnetic resonance imaging, a noninvasive, indirect measure of brain activity.
Every three months after the scan, participants completed an online survey documenting stressful life events and their impact, as well as a questionnaire that assessed symptoms of depression and anxiety.
From the initial 753 participants who were scanned, nearly 200 completed the online surveys an average of two years, and as long as four years, after the scan, the researchers report.
The researchers found that in the individuals who completed the surveys, those who had the more reactive amygdalas at the study’s start also had more severe symptoms of anxiety or depression in response to stressful events after the initial scanning.
Conversely, they also found that participants who had an overzealous amygdala but had not experienced recent stress did not show any elevations in symptoms.
“To find that a single measure of the brain can tell us something important about a person’s psychological vulnerability to stress up to four years later is really remarkable and novel,” said Hariri, a professor of psychology and neuroscience and a member of the Duke Institute for Brain Sciences.
The ability for the brain marker to predict symptoms was surprising, given that the population was healthy and, for the most part, dealing with normal and relatively mild stressors for young adults, like an argument with a parent, or problems at work or school, he noted.
The new research is part of the Duke Neurogenetics Study, a long-term collection of data on genes, brain activity, environmental factors and symptoms related to psychiatric disorders. The ultimate goal is to understand why some people are more vulnerable to developing depression, anxiety, and other mental health problems, the researchers explain.
Hariri and his team continue to follow their study participants.
“We want to know just how far in the future knowing something about an individual’s brain helps us understand their risk,” he said.
The group is also exploring other measures, such as a person’s genes, to predict the differences in amygdala activity, and in turn, the risk for anxiety and depression, he added.
Isolating a person’s DNA from a saliva sample and looking for specific differences in its letter code is easier and less expensive than having them undergo a brain scan, he explained. A genetic screen that tells us about a person’s amygdala reactivity is more likely to be available and useful for doctors working to prevent mental illness in their patients, Hariri concluded.
The study, supported by Duke University, the National Institutes of Health, and the National Institute of Child Health and Human Development, was published in Neuron.
Source: Duke University